Therapeutic Group: atypical antipsychotic Presentation SulmeticTM IV Injection: Each 2ml injectable solution contains Amisulpride BP 5 mg. Description Amisulpride is a selective dopamine-2 (D2) and dopamine-3 (D3) receptor antagonist. D2 receptors are located in the chemoreceptor trigger zone (CTZ) and respond to the dopamine released from the nerve endings. Activation of CTZ relays stimuli to […]